The Pharmaceutical Benefits Advisory Committee (PBAC) is to consider further new hepatitis C medicines at its July 2015 meeting.
Importing medicines to treat your hepatitis C is an option full of pitfalls.
The Therapeutic Goods Administration (TGA) has approved ledipasvir/sofosbuvir (commercial name, Harvoni) for use in treating hepatitis C.
